AccessPak for HIV PEP Expanded with Kaletra and Omacetaxine Subcutaneous
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Omacetaxine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: omacetaxine
Brand name: Synribo
Synonyms: Omacetaxine, Omacetaxine Mepesuccinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Omacor
- AccessPak for HIV PEP Expanded with Kaletra-Omadacycline
- AccessPak for HIV PEP Expanded with Kaletra-Omadacycline Injection
- AccessPak for HIV PEP Expanded with Kaletra-Omadacycline Intravenous
- AccessPak for HIV PEP Expanded with Kaletra-Omadacycline oral/injection
- AccessPak for HIV PEP Expanded with Kaletra-Omadacycline Tablets
- Omacetaxine Subcutaneous-AccessPak for HIV PEP Expanded with Viracept
- Omacetaxine Subcutaneous-Accolate
- Omacetaxine Subcutaneous-Accretropin
- Omacetaxine Subcutaneous-Accucaine
- Omacetaxine Subcutaneous-AccuHist Drops
- Omacetaxine Subcutaneous-AccuHist PDX Drops